causal

Eye as Immune-Privileged Target Site

The retina sits in an immune-privileged site where the immune system has limited access to foreign particles, so a viral-vector gene therapy delivered there triggers less immune reaction, making the eye a smart first target for gene therapy.

causalpending

Speaker

Jeff

Evidence Quote

“when you put a virus or a virus design vector into that space, it is immuno-privileged site. And so therefore, you don't have the same reaction to something that looks foreign.”

Source

Compounding For A Cure— Joys of Compounding
Created: 11/11/2026, 6:53:25 PM

Your notes

Loading notes...